RONN Motor Group
Manufacturing · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1475 N Scottsdale Rd Ste 200, Scottsdale...Phone Number
(480) 498-8989Website
www.ronnmotorgroup.comRevenue
<$5 MillionIndustry
About RONN Motor Group
RONN Motor Group Org Chart
Chief Human Resources Officer
Is RONN Motor Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if RONN Motor Group is spiking on competitors!
Product Launch: Get notified when RONN Motor Group launches new products
Funding: Get notified immidiatlly once RONN Motor Group has new funding data
Check if RONN Motor Group has recently received funding, and reach out quickly before it becomes old news!
Click to see if RONN Motor Group had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
RONN Motor Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at RONN Motor Group
Earning: See what the market has to say on RONN Motor Group recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to RONN Motor Group
Compare insights from companies similar to RONN Motor Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RONN Motor Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RONN Motor Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RONN Motor Group.
RONN Motor Group Tech Stack
A closer look at the technologies used by RONN Motor Group
RONN Motor Group News & Media
Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight Loss Study in China and Phase II Study in the U.S.
BEIJING and BRIDGEWATER, N.J., June 12, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter "Gan & Lee", stockcode: 603087.SH) announced that two of its core pipeline products in the fields of diabetes and obesity treatment have recently achieved positive clinical results....Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide
BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement with JW Pharmaceutical, a leading pharmaceutical company in South Korea. Under the agreement, the two parties will collaborate on the clinical development, regulatory filing, and commercialization in South Korea of Bofanglutide Injection, a bi-weekly (once every two weeks) Glucagon-Like Peptide-1 RecGan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection, have successfully met their pre-specified primary endpoints. After 26 weeks of treatment, once-weekly GZR4 demonstrated statistically significant superior efficacy in reducing glycated hemoglobin A1c (HbA1c)* compared with once-daily insulin glargine U100 (LOnce-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management
BEIJING, Nov. 27, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced the initiation of GRADUAL-3, its third large-scale phase 3 clinical study of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) bofanglutide (research code: GZR18) injection...
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RONN Motor Group
RONN Motor Group, Inc. is a multinational automaker specializing in zero-emission Hydrogen Fuel Cell Electric Vehicles (HFCEV) and sustainable energy solutions. The company offers a diverse range of HFCEV passenger and commercial vehicles, including middle-mile trucks and SUVs. Founded by Ronn Ford, RONN Motor Group collaborates with global automot... Read More